|
Market Closed -
Nasdaq
04:00:00 2026-08-26 pm EDT
|
5-day change | 1st Jan Change | ||
| 440.34 USD | -0.43% |
|
-0.46% | +34.53% |
| 04:30am | AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients | MT |
| 03:36am | AstraZeneca and Amgen announce positive Tezspire trial results in EoE | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 443.84 | 443.84 | 446.85 |
| Spread/Res. | -0.79% | -0.79% | -1.46% |
| Spread/Supp. | +8.77% | +16.22% | +26.61% |
| Support | 404.85 | 378.87 | 347.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
